Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA.
about
Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivoMolecular mechanisms of autoimmunity triggered by microbial infection.An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.Transgenic models for cytokine-induced neurological disease.Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccinesCentral nervous system pathology caused by autoreactive CD8+ T-cell clones following virus infectionInduction of autoreactive CD8+ cytotoxic T cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity.Immunopharmacology of CpG DNA.Antigen-based immune modulation: DNA vectors and beyond.Alteration of T cell cytokine production in PLPp-139-151-induced EAE in SJL mice by an immunostimulatory CpG oligonucleotideMassive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosisGene therapy in autoimmune, demyelinating disease of the central nervous system.Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10.Axonal injury heralds virus-induced demyelination.Sequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity.Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration.DNA vaccines coding for heat-shock proteins (HSPs): tools for the activation of HSP-specific regulatory T cells.Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation.Toll-like receptors in central nervous system glial inflammation and homeostasis.Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosisRole of B:T cell ratio in suppression of clinical signs: a model for silent MSTargeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis.Targeting innate receptors with MIS416 reshapes Th responses and suppresses CNS disease in a mouse model of multiple sclerosis.Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosisMolecular mimicry that primes for autoimmunity which is triggered by infection.Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors.Intramuscular plasmid DNA injection can accelerate autoimmune responses.A recombinant fragment of human SP-D reduces allergic responses in mice sensitized to house dust mite allergens.
P2860
Q24682799-AFFB4A36-EFD3-48D5-A62B-B508D3D5F700Q24812576-DFA8E50F-497D-40E3-AB4D-7CE5BD00CF73Q33788131-906737E2-8B27-42CA-BA47-45FAE0D57CE5Q33852821-F1A65000-5F83-4E27-AC93-6B9FD346B499Q33926168-82EAD204-A696-40C3-9D0E-BF14E3B801EDQ34138616-302A6F08-C3CC-4B3B-A071-4C614D37CBCCQ34142884-30CDDBAD-D089-4E86-A6B0-F235289CD53FQ34352084-993CB823-EC69-496F-901E-8D9BE6F851C5Q35009277-08B6B77E-A9F8-49D5-BBAB-BC4A5053641BQ35040861-ED2487AD-E1A3-4CB8-8891-5FF39DA45046Q35078163-136C7677-F00D-4D07-9474-BE5C2F84B97DQ35094433-F039FA2F-C585-44D6-B489-1728209B3D79Q35122159-28F139B5-6511-4433-85EF-1FA316E5FF63Q35648177-1CDDD143-69B0-4A73-BAA1-945645A37C27Q35749193-3085E270-C024-4A0C-A4B3-54ED99FC0D05Q36004599-ECF6508B-445C-40CD-A5EF-EFD1D9C8AE51Q36095622-A284F2CA-5471-405F-AADA-C97E1550E43FQ36150452-F0458868-3A47-4202-89CF-412A96991118Q36198757-474CD2E3-8929-465C-A89A-92569CEBE69FQ36385464-129C6B38-F623-44C8-A57E-F72619DA9F62Q36422953-588BC6C4-1D3C-4841-855D-0BB5B5E6A130Q36839991-6128CFDB-B18A-4861-8C72-B3B70E86C47FQ37037819-10C9AD14-02E8-40D8-9A40-ACF0AFB7A34BQ37107624-9C61086D-4A5D-458D-B302-C3DD7404CD28Q37316205-A6A3F513-63FC-4F59-84F3-4B0D9111C749Q37539049-9D65F394-BFF9-4E9E-AFB5-00A378980096Q37628560-FA1DF18B-6F09-4BAD-879C-4A2D483FA476Q44079960-E2565C76-FE2D-4DA9-9C7B-C1C06C157342Q44529066-87A1B28F-6E2A-43F0-8505-8FA84F394086Q45880047-AA37CD5D-DC0D-4586-AE6E-61BD61EFB5FDQ51643864-AAF29D37-9F14-4915-A7A2-9EDDD144BCD0
P2860
Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Exacerbation of viral and auto ...... le sclerosis by bacterial DNA.
@en
Exacerbation of viral and auto ...... le sclerosis by bacterial DNA.
@nl
type
label
Exacerbation of viral and auto ...... le sclerosis by bacterial DNA.
@en
Exacerbation of viral and auto ...... le sclerosis by bacterial DNA.
@nl
prefLabel
Exacerbation of viral and auto ...... le sclerosis by bacterial DNA.
@en
Exacerbation of viral and auto ...... le sclerosis by bacterial DNA.
@nl
P2093
P2860
P1433
P1476
Exacerbation of viral and auto ...... le sclerosis by bacterial DNA.
@en
P2093
P2860
P304
P356
10.1111/J.1750-3639.1999.TB00537.X
P577
1999-07-01T00:00:00Z